Jaguar Health, Inc.
Symbol: JAGX (NASDAQ)
4.30
▲ (0.82%) 0.035
Company Description:
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Key Stats
- Today's Open: $4.358
- Today's High: $4.358
- Today's Low: $4.181
- Today's Volume: 1.58K
- Yesterday Close: $4.26
- Yesterday High: $5.33
- Yesterday Low: $4.11
- Yesterday Volume: 450.79K
- Last Min Volume: 0
- Last Min High: $4.295
- Last Min Low: $4.295
- Last Min VWAP: $0
Company Profile
- Name: Jaguar Health, Inc.
- Website: http://www.jaguar.health
- Listed Date: 2015-05-13
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001585608
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.16M
- Round Lot: 100
- Outstanding Shares: 674.01K
- Asset Type: CS
RECENT FILINGS FOR JAGX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-21 | 424B5 | View |
| 2025-05-20 | 4 | View |
| 2025-05-20 | 4 | View |
| 2025-05-15 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-09 | 8-K | View |
| 2025-05-08 | SCHEDULE 13G | View |
| 2025-05-07 | EFFECT | View |
| 2025-05-07 | 424B3 | View |
| 2025-05-05 | 424B5 | View |
| 2025-05-05 | 8-K | View |
| 2025-05-02 | 8-K | View |
| 2025-04-30 | 8-K | View |
| 2025-04-28 | 8-K | View |
| 2025-04-25 | S-3/A | View |
| 2025-04-25 | 8-K/A | View |
| 2025-04-25 | 8-K | View |
| 2025-04-21 | 8-K | View |
| 2025-04-15 | S-8 | View |
| 2025-04-15 | S-3 | View |
Latest News on JAGX